1.
Gaginella TS, Walsh RE: Sulfasalazine: Multiplicity of action. Dig Dis Sci 1992;37:801–812.
2.
Wanders A, Tufveson G, Gerdin B: The enhancing effect of cyclosporine A and sulfasalazine on the prevention of rejection in rat cardiac allografts. Transplant Int 1988;1:113–115.
3.
Fay JW, Wingard JR, Antin JH, Collins RH, Pineiro LA, Blazar BR, Saral R, Bierer BE, Przepiorka D, Fitzsimmons WE, Maher RM, Weisdorf DJ: FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogeneic bone marrow transplantation. Blood 1996;87:3514–3519.
4.
Rains CP, Noble S, Faulds D: Sulfasalazine: A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis. Drugs 1995;50:137–156.
5.
Bird HA: Sulphasalazine, sulphapyridine or 5-aminosalicylic acid – Which is the active moiety in rheumatoid arthritis? Br J Rheumatol 1995;34:16–19.
6.
Fujiwara M, Mitsui K, Yamamoto I: Inhibition of proliferative responses and interleukin 2 productions by salazosulfapyridine and its metabolites. Jpn J Pharmacol 1990;54:121–131.
7.
Wanders A, Tufveson G, Gerdin B: Enhancement of the effect of low-dose cyclosporin A by sulphasalazine in prevention of cardiac allograft rejection in the rat. Transplant Int 1992;5:155–158.
8.
Foster GR: Behçet’s colitis with oesophageal ulceration treated with sulphasalazine and cyclosporin. J R Soc Med 1988;81:545–546.
9.
Laasila K, Leirisalo-Repo M: Side effects of sulphasalazine in patients with rheumatic diseases or inflammatory bowel disease. Scand J Rheumatol 1994;23:338–340.
10.
Selby W: Current management of inflammatory bowel disease. J Gastroenterol Hepatol 1993;8:70–83.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.